
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Annexin A5 as an immune checkpoint inhibitor and tumor-homing molecule for cancer treatment
Tae Heung Kang, Jung Hwa Park, Andrew Yang, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 67
Tae Heung Kang, Jung Hwa Park, Andrew Yang, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 67
Showing 1-25 of 67 citing articles:
Targeting Xkr8 via nanoparticle-mediated in situ co-delivery of siRNA and chemotherapy drugs for cancer immunochemotherapy
Yuang Chen, Yixian Huang, Qinzhe Li, et al.
Nature Nanotechnology (2022) Vol. 18, Iss. 2, pp. 193-204
Open Access | Times Cited: 74
Yuang Chen, Yixian Huang, Qinzhe Li, et al.
Nature Nanotechnology (2022) Vol. 18, Iss. 2, pp. 193-204
Open Access | Times Cited: 74
Nanoplatform‐Based In Vivo Gene Delivery Systems for Cancer Therapy
Rui Luo, Hao Le, Qinjie Wu, et al.
Small (2024) Vol. 20, Iss. 30
Closed Access | Times Cited: 17
Rui Luo, Hao Le, Qinjie Wu, et al.
Small (2024) Vol. 20, Iss. 30
Closed Access | Times Cited: 17
Recent Advances in Stimuli-Responsive Platforms for Cancer Immunotherapy
Ling Li, Zhèn Yáng, Xiaoyuan Chen
Accounts of Chemical Research (2020) Vol. 53, Iss. 10, pp. 2044-2054
Closed Access | Times Cited: 94
Ling Li, Zhèn Yáng, Xiaoyuan Chen
Accounts of Chemical Research (2020) Vol. 53, Iss. 10, pp. 2044-2054
Closed Access | Times Cited: 94
Transforming Growth Factor-β: A Multifunctional Regulator of Cancer Immunity
Vivian Weiwen Xue, Jeff Yat‐Fai Chung, Cristina Alexandra García Córdoba, et al.
Cancers (2020) Vol. 12, Iss. 11, pp. 3099-3099
Open Access | Times Cited: 85
Vivian Weiwen Xue, Jeff Yat‐Fai Chung, Cristina Alexandra García Córdoba, et al.
Cancers (2020) Vol. 12, Iss. 11, pp. 3099-3099
Open Access | Times Cited: 85
The macrophage-associated prognostic gene ANXA5 promotes immunotherapy resistance in gastric cancer through angiogenesis
Zhijun Hong, Peizhen Wen, Kang Wang, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 13
Zhijun Hong, Peizhen Wen, Kang Wang, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 13
Copper Chelate Targeting Externalized Phosphatidylserine Inhibits PD-L1 Expression and Enhances Cancer Immunotherapy
Fan Gao, Wei You, Lei Zhang, et al.
Journal of the American Chemical Society (2025)
Closed Access | Times Cited: 1
Fan Gao, Wei You, Lei Zhang, et al.
Journal of the American Chemical Society (2025)
Closed Access | Times Cited: 1
Annexin Animal Models—From Fundamental Principles to Translational Research
Thomas Grewal, Carles Rentero, Carlos Enrich, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 7, pp. 3439-3439
Open Access | Times Cited: 45
Thomas Grewal, Carles Rentero, Carlos Enrich, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 7, pp. 3439-3439
Open Access | Times Cited: 45
Research progress on the circRNA/lncRNA-miRNA-mRNA axis in gastric cancer
Xuemei Zeng, Juan Xiao, Xue Bai, et al.
Pathology - Research and Practice (2022) Vol. 238, pp. 154030-154030
Closed Access | Times Cited: 33
Xuemei Zeng, Juan Xiao, Xue Bai, et al.
Pathology - Research and Practice (2022) Vol. 238, pp. 154030-154030
Closed Access | Times Cited: 33
Annexin A5 as a targeting agent for cancer treatment
Alexis Woodward, Gabriela N. F. Faria, Roger G. Harrison
Cancer Letters (2022) Vol. 547, pp. 215857-215857
Closed Access | Times Cited: 30
Alexis Woodward, Gabriela N. F. Faria, Roger G. Harrison
Cancer Letters (2022) Vol. 547, pp. 215857-215857
Closed Access | Times Cited: 30
The Relevance, Predictability, and Utility of Annexin A5 for Human Physiopathology
Jian Jing
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2865-2865
Open Access | Times Cited: 8
Jian Jing
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2865-2865
Open Access | Times Cited: 8
Efferocytosis Nanoinhibitors to Promote Secondary Necrosis and Potentiate the Immunogenicity of Conventional Cancer Therapies for Improved Therapeutic Benefits
Yumin Wu, Chunjie Wang, Yifan Yan, et al.
ACS Nano (2023) Vol. 17, Iss. 18, pp. 18089-18102
Closed Access | Times Cited: 16
Yumin Wu, Chunjie Wang, Yifan Yan, et al.
ACS Nano (2023) Vol. 17, Iss. 18, pp. 18089-18102
Closed Access | Times Cited: 16
Phosphatidylserine-Exposing Annexin A1-Positive Extracellular Vesicles: Potential Cancer Biomarkers
Gloria I. Perez, Matthew P. Bernard, Daniel Vocelle, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 639-639
Open Access | Times Cited: 15
Gloria I. Perez, Matthew P. Bernard, Daniel Vocelle, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 639-639
Open Access | Times Cited: 15
Annexin A5 derived from matrix vesicles protects against osteoporotic bone loss via mineralization
Guanyue Su, Demao Zhang, Tiantian Li, et al.
Bone Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 15
Guanyue Su, Demao Zhang, Tiantian Li, et al.
Bone Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 15
Phosphatidylserine externalization as immune checkpoint in cancer
Ivan-Maximilano Kur, Andreas Weigert
Pflügers Archiv - European Journal of Physiology (2024)
Open Access | Times Cited: 5
Ivan-Maximilano Kur, Andreas Weigert
Pflügers Archiv - European Journal of Physiology (2024)
Open Access | Times Cited: 5
Enzyme-Instructed Photoactivatable Supramolecular Antigens on Cancer Cell Membranes for Precision-Controlled T-Cell-Based Cancer Immunotherapy
Yinghao Ding, Shengyi Zhang, Wei Li, et al.
Nano Letters (2024) Vol. 24, Iss. 24, pp. 7397-7407
Closed Access | Times Cited: 4
Yinghao Ding, Shengyi Zhang, Wei Li, et al.
Nano Letters (2024) Vol. 24, Iss. 24, pp. 7397-7407
Closed Access | Times Cited: 4
A Self‐Cascading Catalytic Therapy and Antigen Capture Scaffold‐Mediated T Cells Augments for Postoperative Brain Immunotherapy
Bhanu Nirosha Yalamandala, Thrinayan Moorthy, Zhuo‐Hao Liu, et al.
Small (2024)
Closed Access | Times Cited: 4
Bhanu Nirosha Yalamandala, Thrinayan Moorthy, Zhuo‐Hao Liu, et al.
Small (2024)
Closed Access | Times Cited: 4
In situ vaccine “seeds” for enhancing cancer immunotherapy by exploiting apoptosis-associated morphological changes
Binghua Wang, Rong Guo, Fujun Qiu, et al.
Journal of Controlled Release (2025) Vol. 379, pp. 757-767
Closed Access
Binghua Wang, Rong Guo, Fujun Qiu, et al.
Journal of Controlled Release (2025) Vol. 379, pp. 757-767
Closed Access
Annexin A’s Life in Pan-Cancer: Especially in Glioma Immune Cells
Yongqiang Wen, Wenhao Zhou, Z. Zhao, et al.
NeuroMolecular Medicine (2025) Vol. 27, Iss. 1
Closed Access
Yongqiang Wen, Wenhao Zhou, Z. Zhao, et al.
NeuroMolecular Medicine (2025) Vol. 27, Iss. 1
Closed Access
Identification of an extracellular matrix signature for predicting prognosis and sensitivity to therapy of patients with gastric cancer
Nan Xu, Taojing Zhang, Weiwei Sun, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Nan Xu, Taojing Zhang, Weiwei Sun, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Advancing personalized, predictive, and preventive medicine in bladder cancer: a multi-omics and machine learning approach for novel prognostic modeling, immune profiling, and therapeutic target discovery
Yan Han, Xinyu Ji, Bohan Li
Frontiers in Immunology (2025) Vol. 16
Open Access
Yan Han, Xinyu Ji, Bohan Li
Frontiers in Immunology (2025) Vol. 16
Open Access
ANXA5: related mechanisms of osteogenesis and additional biological functions
Ming Jin, Jingrun Zhang, Yimeng Sun, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Ming Jin, Jingrun Zhang, Yimeng Sun, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Novel phosphatidylserine-binding molecule enhances antitumor T-cell responses by targeting immunosuppressive exosomes in human tumor microenvironments
Maulasri Bhatta, Gautam N. Shenoy, Jenni Loyall, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 10, pp. e003148-e003148
Open Access | Times Cited: 26
Maulasri Bhatta, Gautam N. Shenoy, Jenni Loyall, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 10, pp. e003148-e003148
Open Access | Times Cited: 26
Identification of proteins associated with development of metastasis from cutaneous squamous cell carcinomas (cSCCs) via proteomic analysis of primary cSCCs*
Andrew Shapanis, Chester Lai, Stephen Smith, et al.
British Journal of Dermatology (2020) Vol. 184, Iss. 4, pp. 709-721
Open Access | Times Cited: 26
Andrew Shapanis, Chester Lai, Stephen Smith, et al.
British Journal of Dermatology (2020) Vol. 184, Iss. 4, pp. 709-721
Open Access | Times Cited: 26
Age-Related Gene Alteration in Naïve and Memory T cells Using Precise Age-Tracking Model
Xiaofeng Yang, Xin Wang, Lei Lei, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 8
Open Access | Times Cited: 21
Xiaofeng Yang, Xin Wang, Lei Lei, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 8
Open Access | Times Cited: 21
Improvement of STING-mediated cancer immunotherapy using immune checkpoint inhibitors as a game-changer
Sung‐Eun Lee, Gun-Young Jang, Ji‐Won Lee, et al.
Cancer Immunology Immunotherapy (2022) Vol. 71, Iss. 12, pp. 3029-3042
Closed Access | Times Cited: 15
Sung‐Eun Lee, Gun-Young Jang, Ji‐Won Lee, et al.
Cancer Immunology Immunotherapy (2022) Vol. 71, Iss. 12, pp. 3029-3042
Closed Access | Times Cited: 15